Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q2 2021
Institutional positions in Wave Life Sciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 87
- −15 vs. Q1 2021
- Shares held
- 37.0M
- −1.24M (−3.2%) vs. Q1 2021
- Total value
- $246.7M
- +$31.9M (+14.9%) vs. Q1 2021
- New holders
- 16
- 29 more added
- Sold out
- 31
- 28 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WVE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $1.06B |
| Q1 2026 | 232 | $1.25B |
| Q4 2025 | 219 | $3.11B |
| Q3 2025 | 189 | $1.05B |
| Q2 2025 | 177 | $903.1M |
| Q1 2025 | 197 | $1.06B |
| Q4 2024 | 184 | $1.59B |
| Q3 2024 | 162 | $986.1M |
| Q2 2024 | 144 | $474.4M |
| Q1 2024 | 132 | $572.3M |
| Q4 2023 | 115 | $468.0M |
| Q3 2023 | 85 | $417.4M |
| Q2 2023 | 81 | $262.7M |
| Q1 2023 | 73 | $303.5M |
| Q4 2022 | 75 | $476.9M |
| Q3 2022 | 61 | $242.8M |
| Q2 2022 | 60 | $220.3M |
| Q1 2022 | 82 | $95.4M |
| Q4 2021 | 90 | $148.5M |
| Q3 2021 | 88 | $183.5M |
| Q2 2021 | 87 | $246.7M |
| Q1 2021 | 102 | $214.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Wave Life Sciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −29,870−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −28,504−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −23,266−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −22,605−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −19,471−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,618−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −15,451−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −14,053−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −13,050−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,676−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −10,830−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,871−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,753−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −11,415−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,572−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −929−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |